The Michigan Institute for Clinical and Health Research (MICHR) at the University of Michigan (U-M) has received a $71m grant to advance clinical and translational science.

The seven-year grant was awarded by the National Center for Advancing Translational Science, part of the National Institutes of Health (NIH), under the Clinical and Translational Science Awards (CTSA) programme to improve research and reduce the time taken to bring therapies to market.

MICHR will establish a new behavioural research innovation and support programme to accelerate translational science. The programme will provide the latest training, guidance and resources to optimise support for behavioural research, and see medical institutions work together to bring more treatments to patients more quickly.

U-M medical affairs executive vice president and medical school dean Marschall Runge said: “U-M is dedicated to putting this NIH award toward the advancement of research to improve the lives of humankind.

“With this support, our researchers will continue to search for ways to broaden the impact of translational and clinical research by working together to address the biggest health issues facing us all.”

The participants in the CTSA are responsible for assessing and improving systems within translational research. They need to identify roadblocks to bringing therapies to market, and address them by developing evidence-based solutions.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

MICHR executive director and medical school research associate dean Julie Lumeng said: “This award will position MICHR to lead the way in building the field of translational science, with the intent of extending life and reducing the impact of illness and disability.”